Pfizer Pharma GmbH
Berlin (ots)
A study by the opinion research institute Civey (A) commissioned by Pfizer shows that 56 percent (B) of Germans have had at least one tick bite, and 17 percent (B) have even been bitten more than five times. It is often underestimated that ticks are not only lurking in forests and meadows: 41 percent of people who have had a tick bite were bitten in their own garden. Ticks can transmit tick-borne encephalitis (TBE) viruses when they bite. The numbers warn of caution: with 97 percent (C), almost everyone knows that a TBE infection can even be fatal in severe cases. Nevertheless, only about every third (B) has ever been vaccinated against TBE. The survey results show that doctors play a central role in preventive vaccinations: 60 percent of those surveyed (C) would be vaccinated against TBE if their doctor recommended it.
Vaccination is the best protection against TBE, because the viruses can be transmitted immediately when an infected tick bites. TBE is a disease of the meninges and central nervous system. The consequences can be permanent damage, such as paralysis, swallowing and speech disorders. In severe cases, sufferers are bedridden or confined to a wheelchair. In isolated cases, TBE can also be fatal. “TBE cannot currently be cured with medication. However, vaccination can protect against the disease,” explains Prof. Dr. medical Tomas Jelinek from the Center for Travel Medicine Berlin. “Anyone who needs short-term vaccination protection for the current tick season can use a quick vaccination schedule. The best thing to do is get advice from your family doctor.”
TBE risk areas are spreading, STIKO recommends vaccination
At the beginning of March, the Robert Koch Institute (RKI) identified three new TBE risk areas: the urban district of Munich and the district of Fürstenfeldbruck in Bavaria and the district of Anhalt-Bitterfeld in Saxony-Anhalt. This increases the number of risk areas to a total of 178, and more than 40 percent of all districts in Germany are now affected.(1) The Standing Vaccination Commission (STIKO) recommends TBE vaccination to everyone who lives in a TBE risk area or plans to stay there – for example as part of an excursion – and can come into contact with ticks. For stays in German TBE risk areas, the costs of the vaccination are covered by the statutory health insurance companies. Many health insurance companies also reimburse the costs for trips to foreign risk areas.
Current information on ticks and TBE: www.zecken.de
TBE press page with comprehensive press materials and free image and footage material: www.pfizer.de/tbe-press-materials
About Pfizer – “Breakthroughs that change patients’ lives”
At Pfizer, we use science and our global resources to give people access to therapies that extend and significantly improve their lives. Our aim is to set standards in the discovery, development and manufacture of innovative medicines and vaccines – in terms of their quality, safety and benefit for patients. All over the world – across industrialized and emerging countries – colleagues at Pfizer work every day to improve and advance well-being, prevention, treatment and healing opportunities for the serious diseases of our time. Out of our responsibility as one of the world’s leading innovative biopharmaceutical companies, we work together with healthcare providers, governments and local communities to promote and expand access to reliable and affordable healthcare worldwide. Making a difference for everyone who counts on us is what we’ve been working on for more than 170 years.
Pfizer’s headquarters are in New York. In Germany, more than 3,000 employees work at three locations: Berlin, Freiburg and Karlsruhe. The plant in Freiburg is a pioneer in terms of sustainability and Industry 4.0.
More on www.pfizer.de. Follow us on Twitter @pfizer_de.
Footnotes:
(A) The opinion research company Civey surveyed 5,000 people on behalf of Pfizer between 04/19/2023 and 04/27/2023. The results are representative for the entire German population aged 18 and over. The statistical error of the overall results is 2.5 percent.
(B) Total German population aged 18 and over.
(C) People who have heard of the disease TBE before.
Sources:
(1) Robert Koch Institute (RKI). TBE risk areas in Germany (as of January 2023). Epid Bull 2023; 9:3-22.
Press contact:
Pfizer Pharma GmbH
External Communications
Julia Grommisch
Linkstrasse 10, D-10785 Berlin
Phone: +49 (0)30 – 55 00 55 – 51088
Email: [email protected]
BCW | Burson Cohn & Wolfe
Nicholas Ploger
Darmstadt Landstrasse 112
D-60598 Frankfurt am Main
Telephone: +49 162 1591687
Email: [email protected]
Original content from: Pfizer Pharma GmbH, transmitted by news aktuell
